HEADER TRANSFERASE 14-SEP-09 3JU7 TITLE CRYSTAL STRUCTURE OF PUTATIVE PLP-DEPENDENT AMINOTRANSFERASE TITLE 2 (NP_978343.1) FROM BACILLUS CEREUS ATCC 10987 AT 2.19 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: PUTATIVE PLP-DEPENDENT AMINOTRANSFERASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: DEGT/DNRJ/ERYC1/STRS FAMILY PROTEIN; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BACILLUS CEREUS ATCC 10987; SOURCE 3 ORGANISM_TAXID: 222523; SOURCE 4 ATCC: 10987; SOURCE 5 GENE: BCE_2027, NP_978343.1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS NP_978343.1, PUTATIVE PLP-DEPENDENT AMINOTRANSFERASE, STRUCTURAL KEYWDS 2 GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, PROTEIN KEYWDS 3 STRUCTURE INITIATIVE, PSI-2, PYRIDOXAL PHOSPHATE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 5 01-FEB-23 3JU7 1 REMARK SEQADV REVDAT 4 24-JUL-19 3JU7 1 REMARK LINK REVDAT 3 01-NOV-17 3JU7 1 REMARK REVDAT 2 13-JUL-11 3JU7 1 VERSN REVDAT 1 10-NOV-09 3JU7 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF PUTATIVE PLP-DEPENDENT AMINOTRANSFERASE JRNL TITL 2 (NP_978343.1) FROM BACILLUS CEREUS ATCC 10987 AT 2.19 A JRNL TITL 3 RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.19 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0053 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.19 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.72 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.8 REMARK 3 NUMBER OF REFLECTIONS : 50279 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.179 REMARK 3 R VALUE (WORKING SET) : 0.176 REMARK 3 FREE R VALUE : 0.220 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2571 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.19 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.25 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3427 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.09 REMARK 3 BIN R VALUE (WORKING SET) : 0.2380 REMARK 3 BIN FREE R VALUE SET COUNT : 177 REMARK 3 BIN FREE R VALUE : 0.2730 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5825 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 93 REMARK 3 SOLVENT ATOMS : 300 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 32.56 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.74 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.31000 REMARK 3 B22 (A**2) : -1.19000 REMARK 3 B33 (A**2) : -2.13000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.207 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.179 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.126 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 11.183 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.957 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.935 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 6064 ; 0.015 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 4133 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 8183 ; 1.544 ; 1.967 REMARK 3 BOND ANGLES OTHERS (DEGREES): 10080 ; 0.912 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 738 ; 5.578 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 258 ;34.043 ;24.419 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1035 ;13.931 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 26 ;17.562 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 882 ; 0.087 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 6632 ; 0.007 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 1216 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3677 ; 1.587 ; 3.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1494 ; 0.549 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5909 ; 2.685 ; 5.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2387 ; 5.125 ; 8.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2272 ; 7.231 ;11.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 1 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 1 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 2 A 369 5 REMARK 3 1 B 2 B 369 5 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 1 A (A): 2168 ; 0.110 ; 0.500 REMARK 3 LOOSE POSITIONAL 1 A (A): 2739 ; 0.330 ; 5.000 REMARK 3 MEDIUM THERMAL 1 A (A**2): 2168 ; 0.790 ; 2.000 REMARK 3 LOOSE THERMAL 1 A (A**2): 2739 ; 1.030 ;10.000 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 2 A 369 REMARK 3 ORIGIN FOR THE GROUP (A): 9.9060 57.7432 77.7198 REMARK 3 T TENSOR REMARK 3 T11: 0.0601 T22: 0.0295 REMARK 3 T33: 0.0066 T12: 0.0144 REMARK 3 T13: -0.0017 T23: 0.0056 REMARK 3 L TENSOR REMARK 3 L11: 0.9270 L22: 0.8895 REMARK 3 L33: 0.8720 L12: -0.3932 REMARK 3 L13: -0.3161 L23: 0.1717 REMARK 3 S TENSOR REMARK 3 S11: 0.1064 S12: 0.1493 S13: 0.0533 REMARK 3 S21: -0.2275 S22: -0.0543 S23: 0.0086 REMARK 3 S31: -0.0276 S32: 0.0006 S33: -0.0521 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 2 B 369 REMARK 3 ORIGIN FOR THE GROUP (A): 12.8671 60.0429 110.5372 REMARK 3 T TENSOR REMARK 3 T11: 0.0523 T22: 0.0494 REMARK 3 T33: 0.0154 T12: 0.0072 REMARK 3 T13: -0.0071 T23: -0.0248 REMARK 3 L TENSOR REMARK 3 L11: 0.5311 L22: 0.9860 REMARK 3 L33: 0.9897 L12: -0.1435 REMARK 3 L13: 0.0531 L23: -0.3686 REMARK 3 S TENSOR REMARK 3 S11: -0.0273 S12: -0.1440 S13: 0.0664 REMARK 3 S21: 0.2014 S22: 0.0799 S23: -0.0505 REMARK 3 S31: -0.1047 S32: 0.0312 S33: -0.0526 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: 1.HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. 2.ATOM RECORDS CONTAIN RESIDUAL B FACTORS REMARK 3 ONLY. 3.A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE REMARK 3 INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY OF THE SE REMARK 3 ATOMS IN THE MSE RESIDUES WAS REDUCED TO 0.75 FOR THE REDUCED REMARK 3 SCATTERING POWER DUE TO PARTIAL S-MET INCORPORATION. 4.RESIDUE REMARK 3 LYS190 IN BOTH CHAINS HAS BEEN MODIFIED BY COVALENT MODIFICATION REMARK 3 WITH PLP VIA A SCHIFF BASE FORMATION BETWEEN THE LYSINE AND THE REMARK 3 PLP AND IS MODELED AS LLP. 5.CALCIUM (CA), ACETATE (ACT) AND REMARK 3 PEG300 FRAGMENTS (PEG, PGE) FROM THE CRYSTALLIZATION SOLUTION REMARK 3 HAVE BEEN MODELED IN THE SOLVENT STRUCTURE. REMARK 4 REMARK 4 3JU7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-SEP-09. REMARK 100 THE DEPOSITION ID IS D_1000055164. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-MAY-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL12-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97927 REMARK 200 MONOCHROMATOR : DOUBLE CRYSTAL MONOCHROMATOR REMARK 200 OPTICS : FLAT MIRROR, VERTICAL AND REMARK 200 HORIZONTAL FOCUSSING MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 50328 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.190 REMARK 200 RESOLUTION RANGE LOW (A) : 44.721 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.13600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.8300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.19 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.27 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.1 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.70400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: SHELX, SHELXD, AUTOSHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.76 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.78 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2000M CALCIUM ACETATE, 40.0000% REMARK 280 POLYETHYLENE GLYCOL 300, 0.1M SODIUM CACODYLATE PH 6.5, ADDITIVE: REMARK 280 0.001 M PLP, NANODROP, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 41.19400 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 65.84950 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 45.29300 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 65.84950 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 41.19400 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 45.29300 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: CRYSTAL PACKING ANALYSIS SUPPORTS THE ASSIGNMENT OF A DIMER REMARK 300 AS THE SIGNIFICANT OLIGOMERIC FORM IN SOLUTION. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9010 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25530 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -21.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 MSE A 1 REMARK 465 LYS A 370 REMARK 465 VAL A 371 REMARK 465 VAL A 372 REMARK 465 SER A 373 REMARK 465 ALA A 374 REMARK 465 ASP A 375 REMARK 465 GLU A 376 REMARK 465 GLY B 0 REMARK 465 MSE B 1 REMARK 465 LYS B 370 REMARK 465 VAL B 371 REMARK 465 VAL B 372 REMARK 465 SER B 373 REMARK 465 ALA B 374 REMARK 465 ASP B 375 REMARK 465 GLU B 376 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 2 CG CD OE1 OE2 REMARK 470 ASN A 3 CG OD1 ND2 REMARK 470 GLN A 42 CG CD OE1 NE2 REMARK 470 LYS A 75 CD CE NZ REMARK 470 LYS A 76 CD CE NZ REMARK 470 LYS A 126 CE NZ REMARK 470 GLU A 145 CG CD OE1 OE2 REMARK 470 LYS A 153 CE NZ REMARK 470 GLU A 206 CD OE1 OE2 REMARK 470 LYS A 254 CG CD CE NZ REMARK 470 LYS A 274 CG CD CE NZ REMARK 470 LYS A 275 CG CD CE NZ REMARK 470 LYS A 281 CG CD CE NZ REMARK 470 ARG A 299 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 310 CG CD OE1 NE2 REMARK 470 LYS A 311 CG CD CE NZ REMARK 470 LYS A 344 CD CE NZ REMARK 470 GLN A 369 CG CD OE1 NE2 REMARK 470 GLU B 2 CG CD OE1 OE2 REMARK 470 GLN B 42 CD OE1 NE2 REMARK 470 LYS B 75 CG CD CE NZ REMARK 470 LYS B 76 CD CE NZ REMARK 470 LYS B 126 CE NZ REMARK 470 GLU B 145 CG CD OE1 OE2 REMARK 470 LYS B 153 CD CE NZ REMARK 470 GLU B 206 CG CD OE1 OE2 REMARK 470 GLN B 268 CG CD OE1 NE2 REMARK 470 LYS B 274 CG CD CE NZ REMARK 470 LYS B 281 CD CE NZ REMARK 470 GLU B 297 CG CD OE1 OE2 REMARK 470 ARG B 299 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 309 CD CE NZ REMARK 470 GLN B 310 CG CD OE1 NE2 REMARK 470 LYS B 311 CG CD CE NZ REMARK 470 LYS B 344 CE NZ REMARK 470 GLN B 362 CD OE1 NE2 REMARK 470 GLN B 369 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG B 213 NE - CZ - NH1 ANGL. DEV. = 3.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 31 -166.93 -165.42 REMARK 500 LYS A 126 -129.06 53.37 REMARK 500 PHE A 230 -157.09 -167.72 REMARK 500 THR B 31 -165.10 -163.06 REMARK 500 ASN B 51 29.87 48.96 REMARK 500 LYS B 126 -119.12 49.25 REMARK 500 ASP B 177 16.97 52.86 REMARK 500 PHE B 230 -158.63 -162.85 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 377 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 378 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA A 379 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 380 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 381 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 382 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PEG A 383 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PEG A 384 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PEG A 385 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PGE A 386 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA B 377 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT B 378 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT B 379 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PEG B 380 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PEG B 381 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PEG B 382 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PEG B 383 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PGE B 384 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 390490 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THIS CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE LEAVING REMARK 999 ONLY A GLYCINE (0) FOLLOWED BY THE TARGET SEQUENCE. DBREF 3JU7 A 1 376 UNP Q739W0 Q739W0_BACC1 1 376 DBREF 3JU7 B 1 376 UNP Q739W0 Q739W0_BACC1 1 376 SEQADV 3JU7 GLY A 0 UNP Q739W0 EXPRESSION TAG SEQADV 3JU7 GLY B 0 UNP Q739W0 EXPRESSION TAG SEQRES 1 A 377 GLY MSE GLU ASN ILE PRO PHE LEU ARG ALA SER THR VAL SEQRES 2 A 377 PRO VAL ILE GLU TYR LEU ASP GLU LEU LYS GLU ILE ASP SEQRES 3 A 377 ALA SER HIS ILE TYR THR ASN TYR GLY PRO ILE ASN GLN SEQRES 4 A 377 ARG PHE GLU GLN THR ILE MSE SER GLY PHE PHE GLN ASN SEQRES 5 A 377 ARG GLY ALA VAL THR THR VAL ALA ASN ALA THR LEU GLY SEQRES 6 A 377 LEU MSE ALA ALA ILE GLN LEU LYS LYS ARG LYS LYS GLY SEQRES 7 A 377 LYS TYR ALA LEU MSE PRO SER PHE THR PHE PRO ALA THR SEQRES 8 A 377 PRO LEU ALA ALA ILE TRP CYS GLY LEU GLU PRO TYR PHE SEQRES 9 A 377 ILE ASP ILE SER ILE ASP ASP TRP TYR MSE ASP LYS THR SEQRES 10 A 377 VAL LEU TRP ASP LYS ILE GLU GLU LEU LYS GLU GLU VAL SEQRES 11 A 377 ALA ILE VAL VAL PRO TYR ALA THR PHE GLY SER TRP MSE SEQRES 12 A 377 ASN LEU GLU GLU TYR GLU GLU LEU GLU LYS LYS GLY VAL SEQRES 13 A 377 PRO VAL VAL VAL ASP ALA ALA PRO GLY PHE GLY LEU MSE SEQRES 14 A 377 ASN GLY GLY MSE HIS TYR GLY GLN ASP PHE SER GLY MSE SEQRES 15 A 377 ILE ILE TYR SER PHE HIS ALA THR LLP PRO PHE GLY ILE SEQRES 16 A 377 GLY GLU GLY GLY LEU ILE TYR SER LYS ASN GLU GLU ASP SEQRES 17 A 377 ILE GLN ARG ILE LYS ARG MSE GLY ASN PHE GLY PHE ASP SEQRES 18 A 377 THR ASN ARG GLU CYS THR MSE MSE GLY PHE ASN CYS LYS SEQRES 19 A 377 MSE SER GLU TYR ALA ALA ALA ILE GLY ILE ALA THR MSE SEQRES 20 A 377 LYS LYS TRP ASP ASP LYS LEU LYS GLU ARG THR ARG ILE SEQRES 21 A 377 SER GLU TRP TYR LYS GLN LEU LEU GLN SER ASN GLY LEU SEQRES 22 A 377 MSE LYS LYS GLY TRP GLN LEU GLN LYS THR GLU ALA VAL SEQRES 23 A 377 ILE GLN GLN PHE MSE PRO ILE LEU CYS PRO GLU GLU VAL SEQRES 24 A 377 ARG ASN LYS GLN VAL ILE GLU ASP LEU LYS LYS GLN LYS SEQRES 25 A 377 ILE GLU ALA ARG LEU TYR PHE SER PRO SER CYS HIS GLN SEQRES 26 A 377 GLN VAL LEU PHE ARG ASN TYR LYS SER THR ASP LEU THR SEQRES 27 A 377 ARG THR ASN LYS ILE ALA LYS ARG ILE VAL SER LEU PRO SEQRES 28 A 377 LEU TRP GLU GLY MSE THR LYS GLU ILE VAL GLU GLN ILE SEQRES 29 A 377 VAL ILE CYS LEU GLY GLN LYS VAL VAL SER ALA ASP GLU SEQRES 1 B 377 GLY MSE GLU ASN ILE PRO PHE LEU ARG ALA SER THR VAL SEQRES 2 B 377 PRO VAL ILE GLU TYR LEU ASP GLU LEU LYS GLU ILE ASP SEQRES 3 B 377 ALA SER HIS ILE TYR THR ASN TYR GLY PRO ILE ASN GLN SEQRES 4 B 377 ARG PHE GLU GLN THR ILE MSE SER GLY PHE PHE GLN ASN SEQRES 5 B 377 ARG GLY ALA VAL THR THR VAL ALA ASN ALA THR LEU GLY SEQRES 6 B 377 LEU MSE ALA ALA ILE GLN LEU LYS LYS ARG LYS LYS GLY SEQRES 7 B 377 LYS TYR ALA LEU MSE PRO SER PHE THR PHE PRO ALA THR SEQRES 8 B 377 PRO LEU ALA ALA ILE TRP CYS GLY LEU GLU PRO TYR PHE SEQRES 9 B 377 ILE ASP ILE SER ILE ASP ASP TRP TYR MSE ASP LYS THR SEQRES 10 B 377 VAL LEU TRP ASP LYS ILE GLU GLU LEU LYS GLU GLU VAL SEQRES 11 B 377 ALA ILE VAL VAL PRO TYR ALA THR PHE GLY SER TRP MSE SEQRES 12 B 377 ASN LEU GLU GLU TYR GLU GLU LEU GLU LYS LYS GLY VAL SEQRES 13 B 377 PRO VAL VAL VAL ASP ALA ALA PRO GLY PHE GLY LEU MSE SEQRES 14 B 377 ASN GLY GLY MSE HIS TYR GLY GLN ASP PHE SER GLY MSE SEQRES 15 B 377 ILE ILE TYR SER PHE HIS ALA THR LLP PRO PHE GLY ILE SEQRES 16 B 377 GLY GLU GLY GLY LEU ILE TYR SER LYS ASN GLU GLU ASP SEQRES 17 B 377 ILE GLN ARG ILE LYS ARG MSE GLY ASN PHE GLY PHE ASP SEQRES 18 B 377 THR ASN ARG GLU CYS THR MSE MSE GLY PHE ASN CYS LYS SEQRES 19 B 377 MSE SER GLU TYR ALA ALA ALA ILE GLY ILE ALA THR MSE SEQRES 20 B 377 LYS LYS TRP ASP ASP LYS LEU LYS GLU ARG THR ARG ILE SEQRES 21 B 377 SER GLU TRP TYR LYS GLN LEU LEU GLN SER ASN GLY LEU SEQRES 22 B 377 MSE LYS LYS GLY TRP GLN LEU GLN LYS THR GLU ALA VAL SEQRES 23 B 377 ILE GLN GLN PHE MSE PRO ILE LEU CYS PRO GLU GLU VAL SEQRES 24 B 377 ARG ASN LYS GLN VAL ILE GLU ASP LEU LYS LYS GLN LYS SEQRES 25 B 377 ILE GLU ALA ARG LEU TYR PHE SER PRO SER CYS HIS GLN SEQRES 26 B 377 GLN VAL LEU PHE ARG ASN TYR LYS SER THR ASP LEU THR SEQRES 27 B 377 ARG THR ASN LYS ILE ALA LYS ARG ILE VAL SER LEU PRO SEQRES 28 B 377 LEU TRP GLU GLY MSE THR LYS GLU ILE VAL GLU GLN ILE SEQRES 29 B 377 VAL ILE CYS LEU GLY GLN LYS VAL VAL SER ALA ASP GLU MODRES 3JU7 MSE A 45 MET SELENOMETHIONINE MODRES 3JU7 MSE A 66 MET SELENOMETHIONINE MODRES 3JU7 MSE A 82 MET SELENOMETHIONINE MODRES 3JU7 MSE A 113 MET SELENOMETHIONINE MODRES 3JU7 MSE A 142 MET SELENOMETHIONINE MODRES 3JU7 MSE A 168 MET SELENOMETHIONINE MODRES 3JU7 MSE A 172 MET SELENOMETHIONINE MODRES 3JU7 MSE A 181 MET SELENOMETHIONINE MODRES 3JU7 LLP A 190 LYS MODRES 3JU7 MSE A 214 MET SELENOMETHIONINE MODRES 3JU7 MSE A 227 MET SELENOMETHIONINE MODRES 3JU7 MSE A 228 MET SELENOMETHIONINE MODRES 3JU7 MSE A 234 MET SELENOMETHIONINE MODRES 3JU7 MSE A 246 MET SELENOMETHIONINE MODRES 3JU7 MSE A 273 MET SELENOMETHIONINE MODRES 3JU7 MSE A 290 MET SELENOMETHIONINE MODRES 3JU7 MSE A 355 MET SELENOMETHIONINE MODRES 3JU7 MSE B 45 MET SELENOMETHIONINE MODRES 3JU7 MSE B 66 MET SELENOMETHIONINE MODRES 3JU7 MSE B 82 MET SELENOMETHIONINE MODRES 3JU7 MSE B 113 MET SELENOMETHIONINE MODRES 3JU7 MSE B 142 MET SELENOMETHIONINE MODRES 3JU7 MSE B 168 MET SELENOMETHIONINE MODRES 3JU7 MSE B 172 MET SELENOMETHIONINE MODRES 3JU7 MSE B 181 MET SELENOMETHIONINE MODRES 3JU7 LLP B 190 LYS MODRES 3JU7 MSE B 214 MET SELENOMETHIONINE MODRES 3JU7 MSE B 227 MET SELENOMETHIONINE MODRES 3JU7 MSE B 228 MET SELENOMETHIONINE MODRES 3JU7 MSE B 234 MET SELENOMETHIONINE MODRES 3JU7 MSE B 246 MET SELENOMETHIONINE MODRES 3JU7 MSE B 273 MET SELENOMETHIONINE MODRES 3JU7 MSE B 290 MET SELENOMETHIONINE MODRES 3JU7 MSE B 355 MET SELENOMETHIONINE HET MSE A 45 8 HET MSE A 66 8 HET MSE A 82 8 HET MSE A 113 8 HET MSE A 142 8 HET MSE A 168 8 HET MSE A 172 8 HET MSE A 181 8 HET LLP A 190 24 HET MSE A 214 8 HET MSE A 227 8 HET MSE A 228 8 HET MSE A 234 8 HET MSE A 246 8 HET MSE A 273 8 HET MSE A 290 8 HET MSE A 355 8 HET MSE B 45 8 HET MSE B 66 8 HET MSE B 82 8 HET MSE B 113 8 HET MSE B 142 8 HET MSE B 168 8 HET MSE B 172 8 HET MSE B 181 8 HET LLP B 190 24 HET MSE B 214 8 HET MSE B 227 8 HET MSE B 228 8 HET MSE B 234 8 HET MSE B 246 8 HET MSE B 273 8 HET MSE B 290 8 HET MSE B 355 8 HET CA A 377 1 HET CA A 378 1 HET CA A 379 1 HET ACT A 380 4 HET ACT A 381 4 HET ACT A 382 4 HET PEG A 383 7 HET PEG A 384 7 HET PEG A 385 7 HET PGE A 386 10 HET CA B 377 1 HET ACT B 378 4 HET ACT B 379 4 HET PEG B 380 7 HET PEG B 381 7 HET PEG B 382 7 HET PEG B 383 7 HET PGE B 384 10 HETNAM MSE SELENOMETHIONINE HETNAM LLP (2S)-2-AMINO-6-[[3-HYDROXY-2-METHYL-5- HETNAM 2 LLP (PHOSPHONOOXYMETHYL)PYRIDIN-4- HETNAM 3 LLP YL]METHYLIDENEAMINO]HEXANOIC ACID HETNAM CA CALCIUM ION HETNAM ACT ACETATE ION HETNAM PEG DI(HYDROXYETHYL)ETHER HETNAM PGE TRIETHYLENE GLYCOL HETSYN LLP N'-PYRIDOXYL-LYSINE-5'-MONOPHOSPHATE FORMUL 1 MSE 32(C5 H11 N O2 SE) FORMUL 1 LLP 2(C14 H22 N3 O7 P) FORMUL 3 CA 4(CA 2+) FORMUL 6 ACT 5(C2 H3 O2 1-) FORMUL 9 PEG 7(C4 H10 O3) FORMUL 12 PGE 2(C6 H14 O4) FORMUL 21 HOH *300(H2 O) HELIX 1 1 PRO A 13 GLU A 16 5 4 HELIX 2 2 TYR A 17 HIS A 28 1 12 HELIX 3 3 GLY A 34 PHE A 48 1 15 HELIX 4 4 ASN A 60 LYS A 73 1 14 HELIX 5 5 PRO A 88 CYS A 97 1 10 HELIX 6 6 ASP A 114 LYS A 126 1 13 HELIX 7 7 ALA A 136 SER A 140 5 5 HELIX 8 8 LEU A 144 LYS A 153 1 10 HELIX 9 9 ASN A 204 GLY A 215 1 12 HELIX 10 10 SER A 235 LYS A 248 1 14 HELIX 11 11 LYS A 248 ASN A 270 1 23 HELIX 12 12 ARG A 299 LYS A 309 1 11 HELIX 13 13 SER A 321 ARG A 329 5 9 HELIX 14 14 LEU A 336 ARG A 345 1 10 HELIX 15 15 THR A 356 GLY A 368 1 13 HELIX 16 16 PRO B 13 GLU B 16 5 4 HELIX 17 17 TYR B 17 HIS B 28 1 12 HELIX 18 18 GLY B 34 PHE B 48 1 15 HELIX 19 19 ASN B 60 LYS B 73 1 14 HELIX 20 20 PRO B 88 CYS B 97 1 10 HELIX 21 21 ASP B 114 LYS B 126 1 13 HELIX 22 22 LEU B 144 GLY B 154 1 11 HELIX 23 23 ASN B 204 GLY B 215 1 12 HELIX 24 24 SER B 235 ASN B 270 1 36 HELIX 25 25 ARG B 299 GLN B 310 1 12 HELIX 26 26 SER B 321 ARG B 329 5 9 HELIX 27 27 LEU B 336 ARG B 345 1 10 HELIX 28 28 THR B 356 GLN B 369 1 14 SHEET 1 A 4 ALA A 54 VAL A 58 0 SHEET 2 A 4 GLY A 198 SER A 202 -1 O SER A 202 N ALA A 54 SHEET 3 A 4 MSE A 181 SER A 185 -1 N TYR A 184 O LEU A 199 SHEET 4 A 4 VAL A 158 ASP A 160 1 N VAL A 159 O MSE A 181 SHEET 1 B 3 GLU A 100 ILE A 104 0 SHEET 2 B 3 TYR A 79 PRO A 83 1 N ALA A 80 O GLU A 100 SHEET 3 B 3 VAL A 129 VAL A 132 1 O ALA A 130 N TYR A 79 SHEET 1 C 2 MSE A 168 ASN A 169 0 SHEET 2 C 2 MSE A 172 HIS A 173 -1 O MSE A 172 N ASN A 169 SHEET 1 D 2 MSE A 290 LEU A 293 0 SHEET 2 D 2 ILE A 346 LEU A 349 -1 O LEU A 349 N MSE A 290 SHEET 1 E 4 ALA B 54 VAL B 58 0 SHEET 2 E 4 GLY B 198 SER B 202 -1 O ILE B 200 N THR B 56 SHEET 3 E 4 MSE B 181 SER B 185 -1 N TYR B 184 O LEU B 199 SHEET 4 E 4 VAL B 158 ASP B 160 1 N VAL B 159 O MSE B 181 SHEET 1 F 3 GLU B 100 ILE B 104 0 SHEET 2 F 3 TYR B 79 PRO B 83 1 N ALA B 80 O GLU B 100 SHEET 3 F 3 VAL B 129 VAL B 132 1 O ALA B 130 N TYR B 79 SHEET 1 G 2 MSE B 168 ASN B 169 0 SHEET 2 G 2 MSE B 172 HIS B 173 -1 O MSE B 172 N ASN B 169 SHEET 1 H 2 MSE B 290 LEU B 293 0 SHEET 2 H 2 ILE B 346 LEU B 349 -1 O LEU B 349 N MSE B 290 LINK C ILE A 44 N MSE A 45 1555 1555 1.32 LINK C MSE A 45 N SER A 46 1555 1555 1.32 LINK C LEU A 65 N MSE A 66 1555 1555 1.33 LINK C MSE A 66 N ALA A 67 1555 1555 1.33 LINK C LEU A 81 N MSE A 82 1555 1555 1.32 LINK C MSE A 82 N PRO A 83 1555 1555 1.32 LINK C TYR A 112 N MSE A 113 1555 1555 1.32 LINK C MSE A 113 N ASP A 114 1555 1555 1.33 LINK C TRP A 141 N MSE A 142 1555 1555 1.33 LINK C MSE A 142 N ASN A 143 1555 1555 1.33 LINK C LEU A 167 N MSE A 168 1555 1555 1.33 LINK C MSE A 168 N ASN A 169 1555 1555 1.32 LINK C GLY A 171 N MSE A 172 1555 1555 1.32 LINK C MSE A 172 N HIS A 173 1555 1555 1.34 LINK C GLY A 180 N MSE A 181 1555 1555 1.33 LINK C MSE A 181 N ILE A 182 1555 1555 1.33 LINK C THR A 189 N LLP A 190 1555 1555 1.33 LINK C LLP A 190 N PRO A 191 1555 1555 1.34 LINK C ARG A 213 N MSE A 214 1555 1555 1.34 LINK C MSE A 214 N GLY A 215 1555 1555 1.33 LINK C THR A 226 N MSE A 227 1555 1555 1.33 LINK C MSE A 227 N MSE A 228 1555 1555 1.31 LINK C MSE A 228 N GLY A 229 1555 1555 1.32 LINK C LYS A 233 N MSE A 234 1555 1555 1.32 LINK C MSE A 234 N SER A 235 1555 1555 1.33 LINK C THR A 245 N MSE A 246 1555 1555 1.34 LINK C MSE A 246 N LYS A 247 1555 1555 1.33 LINK C LEU A 272 N MSE A 273 1555 1555 1.33 LINK C MSE A 273 N LYS A 274 1555 1555 1.34 LINK C PHE A 289 N MSE A 290 1555 1555 1.34 LINK C MSE A 290 N PRO A 291 1555 1555 1.33 LINK C GLY A 354 N MSE A 355 1555 1555 1.33 LINK C MSE A 355 N THR A 356 1555 1555 1.33 LINK C ILE B 44 N MSE B 45 1555 1555 1.33 LINK C MSE B 45 N SER B 46 1555 1555 1.33 LINK C LEU B 65 N MSE B 66 1555 1555 1.34 LINK C MSE B 66 N ALA B 67 1555 1555 1.34 LINK C LEU B 81 N MSE B 82 1555 1555 1.33 LINK C MSE B 82 N PRO B 83 1555 1555 1.34 LINK C TYR B 112 N MSE B 113 1555 1555 1.31 LINK C MSE B 113 N ASP B 114 1555 1555 1.33 LINK C TRP B 141 N MSE B 142 1555 1555 1.32 LINK C MSE B 142 N ASN B 143 1555 1555 1.33 LINK C LEU B 167 N MSE B 168 1555 1555 1.33 LINK C MSE B 168 N ASN B 169 1555 1555 1.31 LINK C GLY B 171 N MSE B 172 1555 1555 1.32 LINK C MSE B 172 N HIS B 173 1555 1555 1.32 LINK C GLY B 180 N MSE B 181 1555 1555 1.33 LINK C MSE B 181 N ILE B 182 1555 1555 1.34 LINK C THR B 189 N LLP B 190 1555 1555 1.32 LINK C LLP B 190 N PRO B 191 1555 1555 1.35 LINK C ARG B 213 N MSE B 214 1555 1555 1.32 LINK C MSE B 214 N GLY B 215 1555 1555 1.33 LINK C THR B 226 N MSE B 227 1555 1555 1.33 LINK C MSE B 227 N MSE B 228 1555 1555 1.33 LINK C MSE B 228 N GLY B 229 1555 1555 1.32 LINK C LYS B 233 N MSE B 234 1555 1555 1.32 LINK C MSE B 234 N SER B 235 1555 1555 1.31 LINK C THR B 245 N MSE B 246 1555 1555 1.33 LINK C MSE B 246 N LYS B 247 1555 1555 1.33 LINK C LEU B 272 N MSE B 273 1555 1555 1.34 LINK C MSE B 273 N LYS B 274 1555 1555 1.33 LINK C PHE B 289 N MSE B 290 1555 1555 1.32 LINK C MSE B 290 N PRO B 291 1555 1555 1.34 LINK C GLY B 354 N MSE B 355 1555 1555 1.33 LINK C MSE B 355 N THR B 356 1555 1555 1.33 CISPEP 1 TYR A 317 PHE A 318 0 9.28 CISPEP 2 SER A 319 PRO A 320 0 2.30 CISPEP 3 TYR B 317 PHE B 318 0 4.99 CISPEP 4 SER B 319 PRO B 320 0 3.65 SITE 1 AC1 4 ASP A 19 CA A 379 HOH A 530 HOH A 531 SITE 1 AC2 4 HOH A 533 ARG B 329 HOH B 521 HOH B 535 SITE 1 AC3 6 ASP A 19 CA A 377 HOH A 531 HOH A 532 SITE 2 AC3 6 HOH A 534 ASN B 330 SITE 1 AC4 7 ASN A 32 PHE A 217 ASN A 231 LYS A 233 SITE 2 AC4 7 HOH A 421 HIS B 187 LLP B 190 SITE 1 AC5 6 ARG A 223 HOH A 396 HOH A 398 ARG B 315 SITE 2 AC5 6 LEU B 316 TYR B 317 SITE 1 AC6 1 LYS A 152 SITE 1 AC7 3 THR A 221 ASN A 222 ARG A 223 SITE 1 AC8 5 THR A 189 LLP A 190 GLN A 288 HOH A 443 SITE 2 AC8 5 ACT B 378 SITE 1 AC9 4 LYS A 264 THR A 282 GLU A 283 GLN A 287 SITE 1 BC1 8 TRP A 141 LEU A 144 GLU A 145 MSE A 172 SITE 2 BC1 8 GLY A 175 GLN A 176 ASP A 177 HOH A 527 SITE 1 BC2 4 HOH A 528 ASP B 19 HOH B 520 HOH B 534 SITE 1 BC3 8 HIS A 187 LLP A 190 PEG A 384 ASN B 32 SITE 2 BC3 8 PHE B 217 ASN B 231 LYS B 233 HOH B 475 SITE 1 BC4 6 ARG A 315 LEU A 316 TYR A 317 ARG B 223 SITE 2 BC4 6 HOH B 405 HOH B 461 SITE 1 BC5 2 THR B 221 ASN B 222 SITE 1 BC6 6 THR B 189 LLP B 190 GLN B 288 TYR B 317 SITE 2 BC6 6 HOH B 517 HOH B 531 SITE 1 BC7 3 PHE B 48 MSE B 168 ASP B 250 SITE 1 BC8 5 LYS B 264 GLN B 280 THR B 282 GLU B 283 SITE 2 BC8 5 GLN B 287 SITE 1 BC9 7 TRP B 141 ASN B 143 LEU B 144 GLU B 145 SITE 2 BC9 7 TYR B 174 GLY B 175 ASP B 177 CRYST1 82.388 90.586 131.699 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012138 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011039 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007593 0.00000